Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Davis

Showing results (11-20 of 504) with videos related to

Pageof 51
Sort By:
Journal of Clinical Psychopharmacology|June 23, 2004
Dose response and dose equivalence of antipsychoticsJohn M Davis, Nancy Chen
The Journal of Clinical Psychiatry|December 19, 2003
Choice of maintenance medication for schizophreniaJohn M Davis, Nancy Chen
Evidence-Based Mental Health|January 27, 2006
Intramuscular haloperidol and olanzapine begin to reduce psychosis within 24 hoursStefan Leucht, John M Davis
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2011
Are all antipsychotic drugs the same?Stefan Leucht, John M Davis
Lancet (London, England)|February 11, 2017
Schizophrenia, primary negative symptoms, and soft outcomes in psychiatryStefan Leucht, John M Davis
Schizophrenia Bulletin|March 13, 2008
Has research informed us on the practical drug treatment of schizophrenia?John M Davis, Stefan Leucht
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Is there a differential efficacy of new generation antipsychotic drugs?Stefan Leucht, John M Davis
The Lancet. Psychiatry|October 18, 2020
What is the "best intro"-explanatory versus pragmatic antipsychotic drug trialsStefan Leucht, John M Davis
JAMA Psychiatry|March 1, 2018
Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug OutcomesStefan Leucht, John M Davis
Schizophrenia Bulletin|June 6, 2002
Clinical profile of an atypical antipsychotic: risperidoneJohn M Davis, Nancy Chen
Pageof 51

Showing results (11-20 of 504) with videos related to

Sort By:
Pageof 51
Journal of Clinical Psychopharmacology|June 23, 2004
Dose response and dose equivalence of antipsychoticsJohn M Davis, Nancy Chen
The Journal of Clinical Psychiatry|December 19, 2003
Choice of maintenance medication for schizophreniaJohn M Davis, Nancy Chen
Evidence-Based Mental Health|January 27, 2006
Intramuscular haloperidol and olanzapine begin to reduce psychosis within 24 hoursStefan Leucht, John M Davis
The British Journal of Psychiatry : the Journal of Mental Science|December 22, 2011
Are all antipsychotic drugs the same?Stefan Leucht, John M Davis
Lancet (London, England)|February 11, 2017
Schizophrenia, primary negative symptoms, and soft outcomes in psychiatryStefan Leucht, John M Davis
Schizophrenia Bulletin|March 13, 2008
Has research informed us on the practical drug treatment of schizophrenia?John M Davis, Stefan Leucht
International Journal of Psychiatry in Clinical Practice|June 18, 2014
Is there a differential efficacy of new generation antipsychotic drugs?Stefan Leucht, John M Davis
The Lancet. Psychiatry|October 18, 2020
What is the "best intro"-explanatory versus pragmatic antipsychotic drug trialsStefan Leucht, John M Davis
JAMA Psychiatry|March 1, 2018
Enthusiasm and Skepticism About Using National Registers to Analyze Psychotropic Drug OutcomesStefan Leucht, John M Davis
Schizophrenia Bulletin|June 6, 2002
Clinical profile of an atypical antipsychotic: risperidoneJohn M Davis, Nancy Chen
Pageof 51